...
首页> 外文期刊>Urological Science >Therapeutic effects and predictive factors for successful intravesical hyaluronic acid instillation in patients with interstitial cystitis/bladder pain syndrome
【24h】

Therapeutic effects and predictive factors for successful intravesical hyaluronic acid instillation in patients with interstitial cystitis/bladder pain syndrome

机译:间质性膀胱炎/膀胱疼痛综合征患者成功输注透明质酸的治疗效果和预测因素

获取原文
获取原文并翻译 | 示例

摘要

Objective: Hyaluronic acid (HA) is currently used in Taiwan as intravesical instillation for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS). This study investigated the therapeutic effects of HA on IC/BPS in the Taiwanese population.Materials and methods: Men and women aged >18 years with documented IC/BPS were initially treated with four weekly intravesical HA instillations (treatment time, 1 month) and then with five monthly instillations (total treatment time, 6 months). Clinical assessments included the evaluation of the Visual Analog Scale (VAS) score of bladder pain, O'Leary-Sant Symptom (OSS) score, IC Symptom Index (ICSI), IC Problem Index (ICPI), functional bladder capacity (FBC), uroflowmetry parameters, and global response assessment (GRA). Therapeutic effects were compared between responders (GRA increased > 2 scales) and nonresponders (GRA increased < 2). Multivariate linear analysis was used to determine predictive factor for successful treatment.
机译:目的:透明质酸(HA)目前在台湾用于膀胱内滴注,用于治疗间质性膀胱炎/膀胱疼痛综合征(IC / BPS)。这项研究调查了HA对台湾人群IC / BPS的治疗作用。材料和方法:年龄大于18岁且有记录的IC / BPS的男性和女性,首先接受每周4次膀胱内HA滴注治疗(治疗时间为1个月),然后每月进行5次滴注(总治疗时间为6个月)。临床评估包括评估膀胱疼痛的视觉模拟量表(VAS)评分,O'Leary-Sant症状(OSS)评分,IC症状指数(ICSI),IC问题指数(ICPI),功能性膀胱容量(FBC),尿流测定法参数和整体反应评估(GRA)。比较了有反应者(GRA增加> 2个等级)和无反应者(GRA增加<2)之间的治疗效果。使用多元线性分析确定成功治疗的预测因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号